Identification and characterization of mutations in Ha-Ras that selectively decrease binding to cRaf-1

Area of Science:

• Cellular biology
• Molecular oncology
• Signal transduction

Background:

• The oncoprotein Ras drives cell transformation by interacting with effector proteins.
• Ras effector binding is specific to its GTP-bound state and requires the Ras effector domain.
• While Raf kinases are well-characterized Ras effectors, others like RalGDS and PI3 kinase are also implicated.

Purpose of the Study:

• To elucidate the binding mechanism between cRaf-1 and Ras.
• To investigate the roles of other Ras effector proteins in cellular transformation.
• To characterize Ras mutants with altered cRaf-1 binding affinities.

Main Methods:

• Isolation and characterization of activated Ras mutants.
• Assessment of binding affinities to cRaf-1 and other candidate Ras effectors.
• Analysis of fibroblast transformation, MAP kinase activation, and PI3 kinase activation.

Main Results:

• Ras mutants with reduced cRaf-1 binding were generated.
• Surface-exposed Ras residues outside the effector domain mediate differential interactions with effectors.
• Fibroblast transformation correlated with cRaf-1 binding and MAP kinase activation.
• PI3 kinase activation was observed independently of significant MAP kinase activation.

Conclusions:

• Ras interaction with cRaf-1 is crucial for MAP kinase pathway activation and fibroblast transformation.
• PI3 kinase activation represents a distinct and potentially primary signaling output of Ras.
• Ras utilizes distinct binding interfaces for different effector proteins, enabling pathway specificity.